🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In Current Issue! #biomarkers #Anaphylaxis "Diagnostic Utility of Biomarkers in Anaphylaxis: A Systematic Review and Meta-Analysis": buff.ly/S9l0ULe

In Current Issue!#AI #allergology "ChatGPT Performance on 120 Interdisciplinary Allergology Questions—Systematic Evaluation With Clinical Error Impact Assessment for Critical Erroneous AI-Guided Chatbot Advice": buff.ly/tNAhITc

In Current Issue! #asthma #biomarkers "Poor Agreement Among Asthma Specialists on the Choice and Timing of Initiation of a Biologic Treatment for Severe Asthma Patients": buff.ly/H8n4oSQ

In Current Issue! #inequalities #asthma "Understanding Social Inequalities in Childhood Asthma: Quantifying the Mediating Role of Modifiable Early-Life Risk Factors in Seven European Birth Cohorts": buff.ly/2YAR113

In Current Issue! #anaphylaxis #antibiotics "Hereditary α-tryptasemia is Associated With Anaphylaxis to Antibiotics and Monoclonal Antibodies": buff.ly/YHFw0YR

In Current Issue! #angioedema "Ureteral Edema and Hydronephrosis Associated With Hereditary Angioedema Attack": buff.ly/WnTAfJt

In Current Issue! "Allergy to “Hypoallergenic” Gel Nail Polish": buff.ly/D826ttp

#anaphylaxis #WorldAllergyWeek2025 This week is World Allergy Week! Check out the journal's collection of articles on anaphylaxis: buff.ly/mluRdXL

#drugallergy #WorldAllergyWeek2025 This week is World Allergy Week! Check out the journal's collection of articles on drug allergy: buff.ly/b9ppZXi

The July theme issue on “New advances in asthma care” is now online! Topics include biologics, low T2 asthma, digital health, treatable traits, “treat to target”, rescue inhaled corticosteroid therapy, and disease modification/remission. Check it out here: buff.ly/38nKr6e

The July theme issue on New Advances in Asthma Care is online! Check out an insightful editorial, “New Advances in Asthma Care: Improving Management and Outcomes,” that comprehensively summarizes the cutting-edge review articles in this robust theme issue: buff.ly/lo3P6qB

Listening to "July 2025 Podcast Issue Highlights focusing on the New Advances in Asthma Care" at: buff.ly/LLyejZW

A challenge in asthma management is adherence. Read an article from the new theme issue that discusses electronic medication monitoring to improve adherence, including its benefits, potential disadvantages, and barriers to using this technology: buff.ly/mVO4oLm

Read three asthma biologic articles from the “New Advances in Asthma Care” theme issue covering eliminating corticosteroids, adjusting medications, and using allergen immunotherapy in patients on biologics: buff.ly/4ALXJ4G, buff.ly/Hwl5ZLd, buff.ly/9VfxCFx

Read two articles on rescue inhaled corticosteroid (ICS) therapy from the “New Advances in Asthma Care” theme issue covering the use of rescue ICS in children and the choice of ICS-albuterol versus ICS-formoterol for rescue therapy: buff.ly/wgpfZy5 buff.ly/C6bEUKI

A challenge in asthma management is adherence. Read an article from the “New Advances in Asthma Care” theme that discusses electronic medication monitoring to improve adherence, including its benefits, potential disadvantages, and barriers to use: buff.ly/mVO4oLm

Read the insightful EDITORIAL by Paul Greenberger and Dennis Ledford about the article "Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR Cohort" published in the July issue: buff.ly/VT6iPwu

A challenge in this age of biologics, all but one of which are indicated for high T2 asthma, is the management of low T2 asthma. Read a comprehensive review of the diagnosis and treatment of low T2 asthma from the “New Advances in Asthma Care” theme issue: buff.ly/zfU4hXG

Read the insightful EDITORIAL by Drs. Gerald Teague and Aaron Stein about the article “Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials” published in the July issue: buff.ly/OicdaPG

Read the insightful EDITORIAL by Drs. Ayobami Akenroye and Matthew Moll about the article “α1-Antitrypsin Gene Variation Associates With Asthma Exacerbations and Related Health Care Utilization” published in the July issue: buff.ly/PzYVlwJ